COMPASS 2: Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Pts. with Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, RAndomized, Placebo-Controlled,.....Phase IV Study

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/06 → 12/31/14

Funding

  • Actelion Pharmaceutical Ltd.: $77,754.00